American Association for the Advancement of Science, Science Translational Medicine, 567(12), 2020
DOI: 10.1126/scitranslmed.abb7656
Full text: Unavailable
A modified regimen of benznidazole preventsTrypanosoma cruzidormancy-dependent treatment failure in several mouse models of Chagas disease.